SEARCH

SEARCH BY CITATION

References

  • 1
    Gudjonsson JE, Elder JT. Psoriasis. In: Wolff K , Goldsmith LA , Katz SI , Gilchrest BA , Paller AM , Leffell DJ , eds. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill, 2007:169194.
  • 2
    Baker BS, Swain AF, Fry L, Valdimarsson H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 1984; 110:555564.
  • 3
    Bos JD, Hulsebosch HJ, Krieg SR, Bakker PM, Cormane RH. Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res 1983; 275:181189.
  • 4
    Laggner U, Di Meglio P, Perera GK et al. Identification of a novel proinflammatory human skin-homing Vgamma9Vdelta2 T cell subset with a potential role in psoriasis. J Immunol 2011; 187:27832793.
  • 5
    Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133:377385.
  • 6
    Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004; 51:704708.
  • 7
    Kimball AB, Gladman D, Gelfand JM et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008; 58:10311042.
  • 8
    Elder JT, Bruce AT, Gudjonsson JE et al. Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol 2010; 130:12131226.
  • 9
    Fry L. Psoriasis. Br J Dermatol 1988; 119:445461.
  • 10
    Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 1992; 128:3942.
  • 11
    Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdimarsson H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 2003; 149:530534.
  • 12
    Wardrop P, Weller R, Marais J, Kavanagh G. Tonsillitis and chronic psoriasis. Clin Otolaryngol 1998; 23:6768.
    Direct Link:
  • 13
    Rasmussen JE. The relationship between infection with group A beta hemolytic streptococci and the development of psoriasis. Pediatr Infect Dis J 2000; 19:153154.
  • 14
    Diluvio L, Vollmer S, Besgen P, Ellwart JW, Chimenti S, Prinz JC. Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris. J Immunol 2006; 176:71047111.
  • 15
    Sigurdardottir SL, Thorleifsdottir RH, Valdimarsson H, Johnston A. The role of the palatine tonsils in the pathogenesis and treatment of psoriasis. Br J Dermatol 2013; 168:237242.
  • 16
    Perry M, Whyte A. Immunology of the tonsils. Immunol Today 1998; 19:414421.
  • 17
    Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol 2012; 30:429457.
  • 18
    Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL, Gudjonsson JE, Johnston A. Psoriasis – as an autoimmune disease caused by molecular mimicry. Trends Immunol 2009; 30:494501.
  • 19
    Thorleifsdottir RH, Sigurdardottir SL, Sigurgeirsson B et al. Improvement of psoriasis after tonsillectomy is associated with a decrease in the frequency of circulating T cells that recognize streptococcal determinants and homologous skin determinants. J Immunol 2012; 188:51605165.
  • 20
    Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 1995; 181:747753.
  • 21
    Reddy M, Davis C, Wong J, Prabhakar U. Cutaneous lymphocyte antigen expression on activated lymphocytes and its association with IL-12R (beta1 and beta2), IL-2Ralpha, and CXCR3. Cell Immunol 2005; 236:131139.
  • 22
    Sigmundsdottir H, Johnston A, Gudjonsson JE, Valdimarsson H. Differential effects of interleukin 12 and interleukin 10 on superantigen-induced expression of cutaneous lymphocyte-associated antigen (CLA) and alphaEbeta7 integrin (CD103) by CD8+ T cells. Clin Immunol 2004; 111:119125.
  • 23
    Kryczek I, Bruce AT, Gudjonsson JE et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 2008; 181:47334741.
  • 24
    Harper EG, Guo C, Rizzo H et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 2009; 129:21752183.
  • 25
    Lowes MA, Kikuchi T, Fuentes-Duculan J et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128:12071211.
  • 26
    Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 2010; 130:13731383.
  • 27
    Johnston A, Sigurdardottir SL, Ryon JJ. Isolation of mononuclear cells from tonsillar tissue. Curr Protoc Immunol 2009; Chapter 7: Unit 7 8.
  • 28
    Tsoi LC, Spain SL, Knight J et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012; 44:13411348.
  • 29
    LaPenta D, Rubens C, Chi E, Cleary PP. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci USA 1994; 91:1211512119.
  • 30
    Osterlund A, Popa R, Nikkila T, Scheynius A, Engstrand L. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 1997; 107:640647.
  • 31
    Foote PA, Jr, Brook I. Penicillin and clindamycin therapy in recurrent tonsillitis. Effect of microbial flora. Arch Otolaryngol Head Neck Surg 1989; 115:856859.
  • 32
    Orrling A, Stjernquist-Desatnik A, Schalen C. Clindamycin in recurrent group A streptococcal pharyngotonsillitis – an alternative to tonsillectomy? Acta Otolaryngol 1997; 117:618622.
  • 33
    Owen CM, Chalmers RJ, O'Sullivan T, Griffiths CE. A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol 2001; 145:886890.
  • 34
    Brook I. Failure of penicillin to eradicate group A beta-hemolytic streptococci tonsillitis: causes and management. J Otolaryngol 2001; 30:324329.
  • 35
    Brook I, Leyva F. The treatment of the carrier state of group A beta-hemolytic streptococci with clindamycin. Chemotherapy 1981; 27:360367.
  • 36
    Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005; 43:57215732.
  • 37
    Segata N, Haake SK, Mannon P, Lemon KP, Waldron L, Gevers D, Huttenhower C, Izard J. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol 2012; 13:R42.
  • 38
    Zollner TM, Nuber V, Duijvestijn AM, Boehncke WH, Kaufmann R. Superantigens but not mitogens are capable of inducing upregulation of E-selectin ligands on human T lymphocytes. Exp Dermatol 1997; 6:161166.
  • 39
    Johnston A, Gudjonsson JE, Sigmundsdottir H, Love TJ, Valdimarsson H. Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8 T cells. Clin Exp Immunol 2004; 138:8393.
  • 40
    Sigmundsdottir H, Gudjonsson JE, Jonsdottir I, Ludviksson BR, Valdimarsson H. The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 2001; 126:365369.
  • 41
    Baker BS, Laman JD, Powles A et al. Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions. J Pathol 2006; 209:174181.
  • 42
    Chiricozzi A, Guttman-Yassky E, Suarez-Farinas M et al. Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 2011; 131:677687.
  • 43
    Agren K, Andersson U, Nordlander B et al. Upregulated local cytokine production in recurrent tonsillitis compared with tonsillar hypertrophy. Acta Otolaryngol 1995; 115:689696.
  • 44
    Quiding M, Granstrom G, Nordstrom I, Ferrua B, Holmgren J, Czerkinsky C. High frequency of spontaneous interferon-gamma-producing cells in human tonsils: role of local accessory cells and soluble factors. Clin Exp Immunol 1993; 91:157163.
  • 45
    Kerakawauchi H, Kurono Y, Mogi G. Immune responses against Streptococcus pyogenes in human palatine tonsils. Laryngoscope 1997; 107:634639.
  • 46
    Agren K, Brauner A, Andersson J. Haemophilus influenzae and Streptococcus pyogenes group A challenge induce a Th1 type of cytokine response in cells obtained from tonsillar hypertrophy and recurrent tonsillitis. ORL J Otorhinolaryngol Relat Spec 1998; 60:3541.
  • 47
    Campbell JJ, Murphy KE, Kunkel EJ et al. CCR7 expression and memory T cell diversity in humans. J Immunol 2001; 166:877884.
  • 48
    Brown MN, Fintushel SR, Lee MH et al. Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: changing requirements during the course of inflammation. J Immunol 2010; 185:48734882.
  • 49
    Zhang PC, Pang YT, Loh KS, Wang DY. Comparison of histology between recurrent tonsillitis and tonsillar hypertrophy. Clin Otolaryngol Allied Sci 2003; 28:235239.
  • 50
    Gorfien JL, Hard R, Noble B, Brodsky L. Quantitative study of germinal center area in normal and diseased tonsils using image analysis. Ann Otol Rhinol Laryngol 1999; 108:398402.
  • 51
    Sigurdardottir SL, Thorleifsdottir RH, Guzman AM, Gudmundsson GH, Valdimarsson H, Johnston A. The anti-microbial peptide LL-37 modulates immune responses in the palatine tonsils where it is exclusively expressed by neutrophils and a subset of dendritic cells. Clin Immunol 2012; 142:139149.
  • 52
    Lopez-Gonzalez MA, Diaz P, Delgado F, Lucas M. Lack of lymphoid cell apoptosis in the pathogenesis of tonsillar hypertrophy as compared to recurrent tonsillitis. Eur J Pediatr 1999; 158:469473.
  • 53
    Tabe H, Kawabata I, Koba R, Homma T. Cell dynamics in the germinal center of the human tonsil. Acta Otolaryngol Suppl 1996; 523:6467.
  • 54
    Smith JP, Burton GF, Tew JG, Szakal AK. Tingible body macrophages in regulation of germinal center reactions. Dev Immunol 1998; 6:285294.
  • 55
    Baker BS, Brown DW, Fischetti VA et al. Skin T cell proliferative response to M protein and other cell wall and membrane proteins of group A streptococci in chronic plaque psoriasis. Clin Exp Immunol 2001; 124:516521.
  • 56
    Besgen P, Trommler P, Vollmer S, Prinz JC. Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: potential targets of a streptococcal-induced autoimmune response in psoriasis. J Immunol 2010; 184:53925402.